Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 145 entries
Sorted by: Best Match Show Resources per page
The European Academy laparoscopic "Suturing Training and Testing'' (SUTT) significantly improves surgeons' performance.

Facts, views & vision in ObGyn

Sleiman Z, Tanos V, Van Belle Y, Carvalho JL, Campo R.
PMID: 26977264
Facts Views Vis Obgyn. 2015;7(3):153-60.

UNLABELLED: The efficiency of suturing training and testing (SUTT) model by laparoscopy was evaluated, measuring the suturingskill acquisition of trainee gynecologists at the beginning and at the end of a teaching course. During a workshop organized by the European...

Cite
Sleiman Z, Tanos V, Van Belle Y, et al. The European Academy laparoscopic "Suturing Training and Testing'' (SUTT) significantly improves surgeons' performance. Facts Views Vis Obgyn. 2015;7(3):153-60
Sleiman, Z., Tanos, V., Van Belle, Y., Carvalho, J. L., & Campo, R. (2015). The European Academy laparoscopic "Suturing Training and Testing'' (SUTT) significantly improves surgeons' performance. Facts, views & vision in ObGyn, 7(3), 153-60.
Sleiman, Z, et al. "The European Academy laparoscopic "Suturing Training and Testing'' (SUTT) significantly improves surgeons' performance." Facts, views & vision in ObGyn vol. 7,3 (2015): 153-60.
Sleiman Z, Tanos V, Van Belle Y, Carvalho JL, Campo R. The European Academy laparoscopic "Suturing Training and Testing'' (SUTT) significantly improves surgeons' performance. Facts Views Vis Obgyn. 2015;7(3):153-60. PMID: 26977264; PMCID: PMC4788330.
Copy Download .nbib Format: NLM
The Serotonin Receptor Subtype 5b Specifically Interacts with Serotonin Receptor Subtype 1A.

Frontiers in molecular neuroscience

Niebert S, van Belle GJ, Vogelgesang S, Manzke T, Niebert M.
PMID: 28983239
Front Mol Neurosci. 2017 Sep 21;10:299. doi: 10.3389/fnmol.2017.00299. eCollection 2017.

Previously, we described the dysregulation of serotonin (5-HT) receptor subtype 5b (5-ht

Cite
Niebert S, van Belle GJ, Vogelgesang S, et al. The Serotonin Receptor Subtype 5b Specifically Interacts with Serotonin Receptor Subtype 1A. Front Mol Neurosci. 2017;10:299doi: 10.3389/fnmol.2017.00299.
Niebert, S., van Belle, G. J., Vogelgesang, S., Manzke, T., & Niebert, M. (2017). The Serotonin Receptor Subtype 5b Specifically Interacts with Serotonin Receptor Subtype 1A. Frontiers in molecular neuroscience, 10299. https://doi.org/10.3389/fnmol.2017.00299
Niebert, Sabine, et al. "The Serotonin Receptor Subtype 5b Specifically Interacts with Serotonin Receptor Subtype 1A." Frontiers in molecular neuroscience vol. 10 (2017): 299. doi: https://doi.org/10.3389/fnmol.2017.00299
Niebert S, van Belle GJ, Vogelgesang S, Manzke T, Niebert M. The Serotonin Receptor Subtype 5b Specifically Interacts with Serotonin Receptor Subtype 1A. Front Mol Neurosci. 2017 Sep 21;10:299. doi: 10.3389/fnmol.2017.00299. eCollection 2017. PMID: 28983239; PMCID: PMC5613149.
Copy Download .nbib Format: NLM
Criteria for social media-based scholarship in health professions education.

Postgraduate medical journal

Sherbino J, Arora VM, Van Melle E, Rogers R, Frank JR, Holmboe ES.
PMID: 26275426
Postgrad Med J. 2015 Oct;91(1080):551-5. doi: 10.1136/postgradmedj-2015-133300. Epub 2015 Aug 14.

BACKGROUND: Social media are increasingly used in health professions education. How can innovations and research that incorporate social media applications be adjudicated as scholarship?OBJECTIVE: To define the criteria for social media-based scholarship in health professions education.METHOD: In 2014 the...

Cite
Sherbino J, Arora VM, Van Melle E, et al. Criteria for social media-based scholarship in health professions education. Postgrad Med J. 2015;91(1080):551-5doi: 10.1136/postgradmedj-2015-133300.
Sherbino, J., Arora, V. M., Van Melle, E., Rogers, R., Frank, J. R., & Holmboe, E. S. (2015). Criteria for social media-based scholarship in health professions education. Postgraduate medical journal, 91(1080), 551-5. https://doi.org/10.1136/postgradmedj-2015-133300
Sherbino, Jonathan, et al. "Criteria for social media-based scholarship in health professions education." Postgraduate medical journal vol. 91,1080 (2015): 551-5. doi: https://doi.org/10.1136/postgradmedj-2015-133300
Sherbino J, Arora VM, Van Melle E, Rogers R, Frank JR, Holmboe ES. Criteria for social media-based scholarship in health professions education. Postgrad Med J. 2015 Oct;91(1080):551-5. doi: 10.1136/postgradmedj-2015-133300. Epub 2015 Aug 14. PMID: 26275426.
Copy Download .nbib Format: NLM
Oestrogen and progesterone receptor expression in postmenopausal endometrial polyps and their surrounding endometrium.

European journal of cancer (Oxford, England : 1990)

Thijs I, Neven P, Van Hooff I, Tonglet R, Van Belle Y, De Muylder X, Vanderick G.
PMID: 11056352
Eur J Cancer. 2000 Sep;36:108-9. doi: 10.1016/s0959-8049(00)00263-x.

No abstract available.

Cite
Thijs I, Neven P, Van Hooff I, et al. Oestrogen and progesterone receptor expression in postmenopausal endometrial polyps and their surrounding endometrium. Eur J Cancer. 2000;36:108-9doi: 10.1016/s0959-8049(00)00263-x.
Thijs, I., Neven, P., Van Hooff I, Tonglet, R., Van Belle Y, De Muylder X, & Vanderick, G. (2000). Oestrogen and progesterone receptor expression in postmenopausal endometrial polyps and their surrounding endometrium. European journal of cancer (Oxford, England : 1990), 36108-9. https://doi.org/10.1016/s0959-8049(00)00263-x
Thijs, et al. "Oestrogen and progesterone receptor expression in postmenopausal endometrial polyps and their surrounding endometrium." European journal of cancer (Oxford, England : 1990) vol. 36 (2000): 108-9. doi: https://doi.org/10.1016/s0959-8049(00)00263-x
Thijs I, Neven P, Van Hooff I, Tonglet R, Van Belle Y, De Muylder X, Vanderick G. Oestrogen and progesterone receptor expression in postmenopausal endometrial polyps and their surrounding endometrium. Eur J Cancer. 2000 Sep;36:108-9. doi: 10.1016/s0959-8049(00)00263-x. PMID: 11056352.
Copy Download .nbib Format: NLM
Metastatic Breast Tumour Regression Following Treatment by a Gene-Modified Vaccinia Virus Expressing MUC1 and IL-2.

Journal of biomedicine & biotechnology

Scholl S, Squiban P, Bizouarne N, Baudin M, Acres B, Von Mensdorff-Pouilly S, Shearer M, Beuzeboc P, Van Belle S, Uzielly B, Pouillart P, Taylor-Papadimitriou J, Miles D.
PMID: 12975534
J Biomed Biotechnol. 2003;2003(3):194-201. doi: 10.1155/S111072430320704X.

MUC1 is expressed by glandular epithelial cells. It is overexpressed in the majority of breast tumours, making it a potential target for immune therapy. The objectives of the present study were to evaluate the anti-tumour activity and tolerance of...

Cite
Scholl S, Squiban P, Bizouarne N, et al. Metastatic Breast Tumour Regression Following Treatment by a Gene-Modified Vaccinia Virus Expressing MUC1 and IL-2. J Biomed Biotechnol. 2003;2003(3):194-201doi: 10.1155/S111072430320704X.
Scholl, S., Squiban, P., Bizouarne, N., Baudin, M., Acres, B., Von Mensdorff-Pouilly, S., Shearer, M., Beuzeboc, P., Van Belle, S., Uzielly, B., Pouillart, P., Taylor-Papadimitriou, J., & Miles, D. (2003). Metastatic Breast Tumour Regression Following Treatment by a Gene-Modified Vaccinia Virus Expressing MUC1 and IL-2. Journal of biomedicine & biotechnology, 2003(3), 194-201. https://doi.org/10.1155/S111072430320704X
Scholl, Susy, et al. "Metastatic Breast Tumour Regression Following Treatment by a Gene-Modified Vaccinia Virus Expressing MUC1 and IL-2." Journal of biomedicine & biotechnology vol. 2003,3 (2003): 194-201. doi: https://doi.org/10.1155/S111072430320704X
Scholl S, Squiban P, Bizouarne N, Baudin M, Acres B, Von Mensdorff-Pouilly S, Shearer M, Beuzeboc P, Van Belle S, Uzielly B, Pouillart P, Taylor-Papadimitriou J, Miles D. Metastatic Breast Tumour Regression Following Treatment by a Gene-Modified Vaccinia Virus Expressing MUC1 and IL-2. J Biomed Biotechnol. 2003;2003(3):194-201. doi: 10.1155/S111072430320704X. PMID: 12975534; PMCID: PMC400208.
Copy Download .nbib Format: NLM
Differential inactivation of adenosine by human and canine blood.

FEBS letters

Van Belle H.
PMID: 11946988
FEBS Lett. 1969 Apr;3(2):133-136. doi: 10.1016/0014-5793(69)80116-x.

No abstract available.

Cite
Van Belle H. Differential inactivation of adenosine by human and canine blood. FEBS Lett. 1969;3(2):133-136doi: 10.1016/0014-5793(69)80116-x.
Van Belle, H. (1969). Differential inactivation of adenosine by human and canine blood. FEBS letters, 3(2), 133-136. https://doi.org/10.1016/0014-5793(69)80116-x
Van Belle, H. "Differential inactivation of adenosine by human and canine blood." FEBS letters vol. 3,2 (1969): 133-136. doi: https://doi.org/10.1016/0014-5793(69)80116-x
Van Belle H. Differential inactivation of adenosine by human and canine blood. FEBS Lett. 1969 Apr;3(2):133-136. doi: 10.1016/0014-5793(69)80116-x. PMID: 11946988.
Copy Download .nbib Format: NLM
Open comparative trial of formestane versus megestrol acetate in postmenopausal patients with advanced breast cancer previously treated with tamoxifen.

Breast (Edinburgh, Scotland)

Freue M, Kjaer M, Boni C, Joliver J, Jänicke F, Willemse PH, Coombes RC, Van Belle S, Pérez-Carrión R, Zieschang J, Ibarra de Palacios P, Rose C.
PMID: 14731578
Breast. 2000 Feb;9(1):9-16. doi: 10.1054/brst.1999.0118.

The aim of the trial was to compare efficacy and safety of the aromatase inhibitor formestane (250 mg i.m. given every 2 weeks) with the progestin megestrol acetate (160 mg administered orally once daily), as second-line therapy in postmenopausal...

Cite
Freue M, Kjaer M, Boni C, et al. Open comparative trial of formestane versus megestrol acetate in postmenopausal patients with advanced breast cancer previously treated with tamoxifen. Breast. 2000;9(1):9-16doi: 10.1054/brst.1999.0118.
Freue, M., Kjaer, M., Boni, C., Joliver, J., Jänicke, F., Willemse, P. H., Coombes, R. C., Van Belle, S., Pérez-Carrión, R., Zieschang, J., Ibarra de Palacios, P., & Rose, C. (2000). Open comparative trial of formestane versus megestrol acetate in postmenopausal patients with advanced breast cancer previously treated with tamoxifen. Breast (Edinburgh, Scotland), 9(1), 9-16. https://doi.org/10.1054/brst.1999.0118
Freue, M, et al. "Open comparative trial of formestane versus megestrol acetate in postmenopausal patients with advanced breast cancer previously treated with tamoxifen." Breast (Edinburgh, Scotland) vol. 9,1 (2000): 9-16. doi: https://doi.org/10.1054/brst.1999.0118
Freue M, Kjaer M, Boni C, Joliver J, Jänicke F, Willemse PH, Coombes RC, Van Belle S, Pérez-Carrión R, Zieschang J, Ibarra de Palacios P, Rose C. Open comparative trial of formestane versus megestrol acetate in postmenopausal patients with advanced breast cancer previously treated with tamoxifen. Breast. 2000 Feb;9(1):9-16. doi: 10.1054/brst.1999.0118. PMID: 14731578.
Copy Download .nbib Format: NLM
A Unified Approach of Meta-Analysis: Application to an Antecedent Biomarker Study in Alzheimer's Disease.

Journal of applied statistics

Xiong C, van Belle G, Zhu K, Miller JP, Morris JC.
PMID: 21221414
J Appl Stat. 2011 Jan 01;38(1):15-27. doi: 10.1080/02664760903008987.

This article provides a unified methodology of meta-analysis that synthesizes medical evidence by using both available individual patient data (IPD) and published summary statistics within the framework of likelihood principle. Most up-to-date scientific evidence on medicine is crucial information...

Cite
Xiong C, van Belle G, Zhu K, et al. A Unified Approach of Meta-Analysis: Application to an Antecedent Biomarker Study in Alzheimer's Disease. J Appl Stat. 2011;38(1):15-27doi: 10.1080/02664760903008987.
Xiong, C., van Belle, G., Zhu, K., Miller, J. P., & Morris, J. C. (2011). A Unified Approach of Meta-Analysis: Application to an Antecedent Biomarker Study in Alzheimer's Disease. Journal of applied statistics, 38(1), 15-27. https://doi.org/10.1080/02664760903008987
Xiong, Chengjie, et al. "A Unified Approach of Meta-Analysis: Application to an Antecedent Biomarker Study in Alzheimer's Disease." Journal of applied statistics vol. 38,1 (2011): 15-27. doi: https://doi.org/10.1080/02664760903008987
Xiong C, van Belle G, Zhu K, Miller JP, Morris JC. A Unified Approach of Meta-Analysis: Application to an Antecedent Biomarker Study in Alzheimer's Disease. J Appl Stat. 2011 Jan 01;38(1):15-27. doi: 10.1080/02664760903008987. PMID: 21221414; PMCID: PMC3017356.
Copy Download .nbib Format: NLM
Clinical management of immunocompetent hospitalized patients with community-acquired pneumonia.

European journal of internal medicine

Lamy O, Van Melle G, Cornuz J, Burnand B.
PMID: 15066645
Eur J Intern Med. 2004 Feb;15(1):28-34. doi: 10.1016/j.ejim.2003.11.003.

Background: Clinical practices and guidelines may differ regarding the management of inpatients with community-acquired pneumonia (CAP). Methods: The management of 152 consecutive CAP inpatients (70+/-17 years) admitted to a teaching hospital was analyzed retrospectively and compared with published data...

Cite
Lamy O, Van Melle G, Cornuz J, et al. Clinical management of immunocompetent hospitalized patients with community-acquired pneumonia. Eur J Intern Med. 2004;15(1):28-34doi: 10.1016/j.ejim.2003.11.003.
Lamy, O., Van Melle, G., Cornuz, J., & Burnand, B. (2004). Clinical management of immunocompetent hospitalized patients with community-acquired pneumonia. European journal of internal medicine, 15(1), 28-34. https://doi.org/10.1016/j.ejim.2003.11.003
Lamy, Olivier, et al. "Clinical management of immunocompetent hospitalized patients with community-acquired pneumonia." European journal of internal medicine vol. 15,1 (2004): 28-34. doi: https://doi.org/10.1016/j.ejim.2003.11.003
Lamy O, Van Melle G, Cornuz J, Burnand B. Clinical management of immunocompetent hospitalized patients with community-acquired pneumonia. Eur J Intern Med. 2004 Feb;15(1):28-34. doi: 10.1016/j.ejim.2003.11.003. PMID: 15066645.
Copy Download .nbib Format: NLM
Combining Multiple Markers to Improve the Longitudinal Rate of Progression-Application to Clinical Trials on the Early Stage of Alzheimer's Disease.

Statistics in biopharmaceutical research

Xiong C, van Belle G, Chen K, Tian L, Luo J, Gao F, Yan Y, Chen L, Morris JC, Crane P.
PMID: 24363827
Stat Biopharm Res. 2013 Jan 01;5(1). doi: 10.1080/19466315.2012.756662.

Clinical trials on early stage Alzheimer's disease (AD) are reaching a bottleneck because none of the current disease markers changes appreciably early in the disease process and therefore a huge sample is required to adequately power such trials. We...

Cite
Xiong C, van Belle G, Chen K, et al. Combining Multiple Markers to Improve the Longitudinal Rate of Progression-Application to Clinical Trials on the Early Stage of Alzheimer's Disease. Stat Biopharm Res. 2013;5(1)doi: 10.1080/19466315.2012.756662.
Xiong, C., van Belle, G., Chen, K., Tian, L., Luo, J., Gao, F., Yan, Y., Chen, L., Morris, J. C., & Crane, P. (2013). Combining Multiple Markers to Improve the Longitudinal Rate of Progression-Application to Clinical Trials on the Early Stage of Alzheimer's Disease. Statistics in biopharmaceutical research, 5(1), . https://doi.org/10.1080/19466315.2012.756662
Xiong, Chengjie, et al. "Combining Multiple Markers to Improve the Longitudinal Rate of Progression-Application to Clinical Trials on the Early Stage of Alzheimer's Disease." Statistics in biopharmaceutical research vol. 5,1 (2013). doi: https://doi.org/10.1080/19466315.2012.756662
Xiong C, van Belle G, Chen K, Tian L, Luo J, Gao F, Yan Y, Chen L, Morris JC, Crane P. Combining Multiple Markers to Improve the Longitudinal Rate of Progression-Application to Clinical Trials on the Early Stage of Alzheimer's Disease. Stat Biopharm Res. 2013 Jan 01;5(1). doi: 10.1080/19466315.2012.756662. PMID: 24363827; PMCID: PMC3868484.
Copy Download .nbib Format: NLM
One-year clinical follow-up of a registry evaluating a percutaneous revascularisation strategy combining a pre-specified simple selection process with the use of a new thin-strut bare cobalt-chromium stent.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Stella PR, Pavlakis G, Agostoni P, Nathoe HM, Hoseyni Guyomi S, Hamer BJ, Wildbergh TX, Doevendans PA, Van Belle E.
PMID: 20978593
Neth Heart J. 2010 Oct;18(10):486-92. doi: 10.1007/BF03091820.

Objectives. To evaluate clinical events in a specifically selected cohort of patients with obstructive coronary artery disease (CAD), using a new generation thin-strut bare cobalt-chromium coronary stent.Methods. Patients with single- or multi-vessel, stable or unstable CAD eligible for percutaneous...

Cite
Stella PR, Pavlakis G, Agostoni P, et al. One-year clinical follow-up of a registry evaluating a percutaneous revascularisation strategy combining a pre-specified simple selection process with the use of a new thin-strut bare cobalt-chromium stent. Neth Heart J. 2010;18(10):486-92doi: 10.1007/BF03091820.
Stella, P. R., Pavlakis, G., Agostoni, P., Nathoe, H. M., Hoseyni Guyomi, S., Hamer, B. J., Wildbergh, T. X., Doevendans, P. A., & Van Belle, E. (2010). One-year clinical follow-up of a registry evaluating a percutaneous revascularisation strategy combining a pre-specified simple selection process with the use of a new thin-strut bare cobalt-chromium stent. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 18(10), 486-92. https://doi.org/10.1007/BF03091820
Stella, P R, et al. "One-year clinical follow-up of a registry evaluating a percutaneous revascularisation strategy combining a pre-specified simple selection process with the use of a new thin-strut bare cobalt-chromium stent." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 18,10 (2010): 486-92. doi: https://doi.org/10.1007/BF03091820
Stella PR, Pavlakis G, Agostoni P, Nathoe HM, Hoseyni Guyomi S, Hamer BJ, Wildbergh TX, Doevendans PA, Van Belle E. One-year clinical follow-up of a registry evaluating a percutaneous revascularisation strategy combining a pre-specified simple selection process with the use of a new thin-strut bare cobalt-chromium stent. Neth Heart J. 2010 Oct;18(10):486-92. doi: 10.1007/BF03091820. PMID: 20978593; PMCID: PMC2954301.
Copy Download .nbib Format: NLM
Using computer technology to foster learning for understanding.

Microbiology education

VAN Melle E, Tomalty L.
PMID: 23653533
Microbiol Educ. 2000 May;1:7-13. doi: 10.1128/me.1.1.7-13.2000.

The literature shows that students typically use either a surface approach to learning, in which the emphasis is on memorization of facts, or a deep approach to learning, in which learning for understanding is the primary focus. This paper...

Cite
VAN Melle E, Tomalty L. Using computer technology to foster learning for understanding. Microbiol Educ. 2000;1:7-13doi: 10.1128/me.1.1.7-13.2000.
VAN Melle, E., & Tomalty, L. (2000). Using computer technology to foster learning for understanding. Microbiology education, 17-13. https://doi.org/10.1128/me.1.1.7-13.2000
VAN Melle, E, and Tomalty, L. "Using computer technology to foster learning for understanding." Microbiology education vol. 1 (2000): 7-13. doi: https://doi.org/10.1128/me.1.1.7-13.2000
VAN Melle E, Tomalty L. Using computer technology to foster learning for understanding. Microbiol Educ. 2000 May;1:7-13. doi: 10.1128/me.1.1.7-13.2000. PMID: 23653533; PMCID: PMC3633098.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 145 entries